HIF-SEQ

Welcome to the Brand page for “HIF-SEQ”, which is offered here for Research and development of pharmaceuticals for the treatment of neurodegenerative diseases, brain cancer, and brain tumors; providing information about medical research in the field of neurodegenerative diseases, brain cancer, and tumors; research and development in the pharmaceutical and biotechnology fields; research and development services in the fields of custom chemistry, dna sequencing and quantification, assay design, testing and analysis, bioinfomatics and biological data analysis, and biological image processing and data extraction, and consultation services related thereto;.

Its status is currently believed to be active. Its class is unavailable. “HIF-SEQ” is believed to be currently owned by “Valted Seq, Inc.”


Owner:
VALTED SEQ, INC.
Owner Details
Description:
Research and development of pharmaceuticals for the treatment of neurodegenerative diseases, brain cancer, and brain tumors; providing information about medical research in the field of neurodegenerative diseases, brain cancer, and tumors; research and development in the pharmaceutical and biotechnology fields; Research and development services in the fields of custom chemistry, DNA sequencing and quantification, assay design, testing and analysis, bioinfomatics and biological data analysis, and biological image processing and data extraction, and consultation services related thereto;
Categories: RESEARCH DEVELOPMENT PHARMACEUTICALS